FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients

NCT01864083 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

PROCEDURE: Positron Emission Tomography (PET)
DRUG: Fluorine-18 labeled 1-amino-3-fluorocyclobutane-1-carboxylic acid (FACBC)
PROCEDURE: Positron emission mammography (PEM) When available
PROCEDURE: MR

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]